News
WA State “stem cell clinics” will now need to post “therapies” are not FDA regulated
March 27, 2018 | Categories: AnnouncementsOn Thursday, March 22, Governor Inslee signed into law House Bill 2356. This legislation will require Washington State “stem-cell clinics” to post a visible notice that their injection procedures are not FDA-approved and that patients should consult with primary-care providers before undergoing one. Read More
Goodbye to a great alumnus and friend, Orin Smith
March 6, 2018 | Categories: AnnouncementsThe University of Washington is saying goodbye to a wonderful friend and alumnus in Orin Smith. Orin’s involvement in numerous areas left an indelible mark on the University, and we were exceptionally fortunate to benefit from his leadership and support at ISCRM for more than a decade. In fact, Orin was one of the earliest supporters of ISCRM and the creation of the UW Medicine South Lake Union Campus. Read More
Stem-cell study points to new approach to Alzheimer’s disease
March 1, 2018 | Categories: Research |Improving the trafficking of cellular proteins in brain cells holds possibilities for new treatments and even prevention for Alzheimer’s disease, results of a new study suggest. Researchers found that a compound that enhances the shuttling of proteins within cells reduced the production of forerunners of two proteins implicated in brain cell death. Read More
2018 ISCRM Travel Awards Announced
February 5, 2018 | Categories: AnnouncementsCongratulations to this year’s winners of the 2018 Travel Awards. Each travel award is in the amount of $1,000 to be applied toward travel to the June 2018 ISSCR meeting in Melbourne, Australia. Read More
Researchers program biomaterials with ‘logic gates’ that release therapeutics in response to environmental triggers
January 16, 2018 | Categories: Research |Drug treatments can save lives, but sometimes they also carry unintended costs. After all, the same therapeutics that target pathogens and tumors can also harm healthy cells. To reduce this collateral damage, scientists have long sought specificity in drug delivery systems: A package that can encase a therapeutic and will not disgorge its toxic cargo until it reaches the site of treatment — be it a tumor, a diseased organ or a site of infection. Read More
Study: Using big data to help fight a deadly cancer
January 12, 2018 | Categories: Research |Researchers built an algorithm to discern which drugs might best combat patients’ individual cases of acute myeloid leukemia. The statistics are grim. For patients fighting an aggressive form of leukemia known as acute myeloid leukemia, or AML, doctors over the last 40 years have usually used a combination of two drugs to fight the disease, but it seldom cures it. Read More
Favorable interim results reported in stem-cell therapy trial
January 8, 2018 | Categories: Research |A therapy developed at UW shows promise in its first test in young boys who have an inherited deadly muscle disease. Favorable interim results have been announced in a small clinical trial of a stem-cell therapy to treat patients with a rare, deadly disease called myotubular myopathy. Read More
ISCRM Awards State Funding for Scholars and Pilot Programs
November 30, 2017 | Categories: Announcements |Congratulations to the 2017 ISCRM Scholars and Innovation Pilot Program Awardees The ISCRM Scholars Program, funded by the State of Washington, is a newly established program that provides one year of funding for predoctoral and postdoctoral trainees doing research in stem cell and regenerative medicine technologies. Each of the six scholars selected for the 2017 […] Read More
Network of synthetic blood microvessels built
October 4, 2017 | Categories: Research |Researchers are reporting significant progress in generating a 3-dimensional network of blood vessels that can be grown and manipulated in a laboratory. Building vascular support for stem-cell repaired tissues or replacement organs will be vital to such regenerative therapies. Read More
Mini-kidney organoids reveal renal disease secrets
October 2, 2017 | Categories: Research |Kidney organoids are revealing both the factors that influence the formation of kidney cysts, as well as how the disease progresses. The organoids are grown in labware from human stem cells. Polycystic kidney disease affects 12 million people. Until recently, scientists have been unable to recreate the progression of this human disease in a laboratory setting. Read More
Calendar
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
|
29
|
30
|
31
|
1
|
2
|
3
|
4
|
|
5
|
6
|
8
|
9
|
10
|
11
|
|
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
|
19
|
20
|
22
|
23
|
24
|
25
|
|
|
26
|
27
|
28
|
29
|
30
|
1
|
2
|
